Dramatic response of cutaneous, nail, and joint symptoms of psoriasis to apremilast
Apremilast has been available in India for the past 6 months as a therapy for psoriasis. A 31-year-old male patient with a diagnosis of psoriasis with oligoarthritis who was not tolerating methotrexate was treated with apremilast. We noticed a dramatic response to the cutaneous and joint symptom wit...
Saved in:
Main Authors: | Meghana Bathina (Author), Amina Asfiya Iqbal (Author), Malcolm Pinto (Author), Manjunath M Shenoy (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016) -
Apremilast for lithium-associated psoriasis
by: Joohyung Youh, et al.
Published: (2022) -
Treatment of erythrodermic psoriasis with apremilast
by: Olivia A. Gioe, MD, et al.
Published: (2021) -
A Case of Yellow Nail Syndrome with Dramatically Improved Nail Discoloration by Oral Clarithromycin
by: Manabu Suzuki, et al.
Published: (2011) -
Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
by: Gao JC, et al.
Published: (2022)